A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Clinical trial NCT05420545 · UNKNOWN

Trial details

NCT number: NCT05420545
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Tumor Advanced Solid Tumor Renal Cell Carcinoma Ovarian Cancer Cervix Cancer

Start date: 2021-12-31
Primary completion: 2023-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.